Larvol Delta - A-dose-escalation-and-cohort-expansion-phase-IIIa-study-of-ACR246-an-innovative-5T4-antibody-drug-conjugate-ADC-in-patients-pts-with-advanced-solid-tumors

ACR246 - Adcoris

https://meetings.asco.org/abstracts-presentations/252290/

Panpan Zhang; Yunsheng Huang; Lina Chen; Feng Wang; Zhenwei Miao

Apr 23, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next